PMID: 9442386Jan 27, 1998Paper

Interleukin-6 and CAAT/enhancer binding protein beta-deficient mice act as tools to dissect the IL-6 signalling pathway and IL-6 regulation

Immunobiology
T AlonziV Poli

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine playing important roles in immunity, hemopoiesis and inflammation. IL-6 signalling is known to involve the activation of two independent transcription factors: Stat3 (through phosphorylation by Jak kinases) and C/EBP beta (through activation of the ras pathway). In addition, C/EBP beta is believed to act as a transcriptional activator of the IL-6 gene itself. Making use of IL-6-deficient mice, we have recently demonstrated that IL-6 is essential for the induction of acute phase mRNAs in the liver upon localized tissue damage, but not upon systemically induced inflammation. Here we show that the defective mRNA induction is paralleled by a defective activation of Stat3, thus establishing a direct relationship between IL-6 function, Stat3 activation and acute phase genes induction. On the other hand, making use of C/EBP beta-deficient mice, we show that the induction of IL-6 by a variety of stimuli does not require C/EBP beta activity. In contrast to the predicted activating role of C/EBP beta, IL-6 levels are increased in the C/EBP beta-deficient mice, suggesting that C/EBP beta may act as a down-modulator of the IL-6 gene. Through the generation of C/EBP beta, IL-6 double mutant mic...Continue Reading

References

Jan 1, 1995·Annual Review of Biochemistry·C Schindler, J E Darnell
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·P M WaringD Metcalf
Oct 1, 1994·The Journal of Experimental Medicine·E FattoriV Poli

❮ Previous
Next ❯

Citations

Oct 17, 2001·Developmental and Comparative Immunology·D R Barreda, M Belosevic
Jun 8, 2001·Alcoholism, Clinical and Experimental Research·A M Diehl
Jan 27, 2004·Infection and Immunity·Jeffrey A GoldMichael D Weiden
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shaikh Mizanoor RahmanJacob E Friedman
Sep 10, 2013·Cell Metabolism·Liping ZhangWilliam E Mitch
Jun 11, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Vimal SelvarajPaul S Cooke
Nov 13, 1998·The Journal of Biological Chemistry·A M Diehl
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C GeorganasR M Pope

❮ Previous
Next ❯

Related Concepts

Related Feeds

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.